SCHEMBL377189

SCHEMBL377189

CC1(C)CC(N)C(C)(C)N1[O]

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912919 0.76
Tempamine SCHEMBL50504 0.74 CA1 (0.31)
SCHEMBL7636853 0.72 GAA (0.31) GAAL3MBTL1
SCHEMBL14165287 0.72 GAA (0.31) GAAL3MBTL1
SCHEMBL377190 0.70 GAA (0.56) GAAL3MBTL1
SCHEMBL18545708 0.70 GAA (0.56) GAAL3MBTL1
SCHEMBL668940 0.70 GAA (0.56) GAAL3MBTL1
SCHEMBL16245364 0.70 GAA (0.30) GAAL3MBTL1
SCHEMBL50368 0.70
SCHEMBL9982847 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 456 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2981560-B1 CURING OF LIQUID THERMOSETTING RESINS REICHHOLD LLC 2 (US) 2021-10-13 EP claimed
US-10793505-B2 Unit and process for purification of crude methyl methacrylate ARKEMA FRANCE (FR) 2020-10-06 US claimed
US-10544299-B2 Vinyl-containing compounds with high heat distortion REICHHOLD LLC 2 (US) 2020-01-28 US claimed
US-20160251297-A1 UNIT AND PROCESS FOR PURIFICATION OF CRUDE METHYL METHACRYLATE ALTER DOMUS (US) LLC 2016-09-01 US claimed
CN-105636929-A Unit and process for purification of crude methyl methacrylate ARKEMA FRANCE 2016-06-01 CN claimed
EP-2981560-A1 CURING OF LIQUID THERMOSETTING RESINS Reichhold, Inc. (US) 2016-02-10 EP claimed
US-9068045-B2 Curing of liquid thermosetting resins REICHHOLD, INC. (US) 2015-06-30 US claimed
US-20140303315-A1 CURING OF LIQUID THERMOSETTING RESINS Polynt Composites USA Inc. 2014-10-09 US claimed
WO-2014165425-A1 CURING OF LIQUID THERMOSETTING RESINS REICHHOLD, INC. (US) 2014-10-09 WO claimed
US-20140171568-A1 VINYL-CONTAINING COMPOUNDS WITH HIGH HEAT DISTORTION Polynt Composites USA Inc. 2014-06-19 US claimed
US-20050049442-A1 Stabilized polychloroethylenes PPG INDUSTRIES OHIO, INC. 2005-03-03 US claimed
US-20040039237-A1 Trichloroethane, is stabilized with a stabilizing amount of a stable free radical stabilizer, such as, 2,2,6,6,-tetra (lower alkyl)-1-piperidinyloxy-yl free radical group PPG INDUSTRIES OHIO, INC. 2004-02-26 US claimed
US-20040010159-A1 Blends of quinone alkide and nitroxyl compounds and polymerization inhibitors ADDIVANT USA, LLC 2004-01-15 US claimed
US-6500982-B1 DEHYDRATION IN PRESENCE OF POLYMERIZATION INHIBITOR WITH TURNDOWN CONTROL, I.E. ADJUSTING WATER OR ORGANIC SOLVENT FED TO MAINTAIN OPTIMAL DISTILLATION COLUMN PERFORMANCE ROHM AND HAAS COMPANY 2002-12-31 US claimed
EP-1065197-B1 Process for preparing (meth)acrylic acid ROHM & HAAS (US) 2002-11-06 EP claimed
US-20020123658-A1 Recycle of nitroxyl-containing streams at low temperature CROMPTON CORPORATION 2002-09-05 US claimed
EP-1235885-A1 COMPOSITION AND METHOD FOR INHIBITING POLYMERIZATION AND POLYMER GROWTH Uniroyal Chemical Company, Inc. (US) 2002-09-04 EP claimed
WO-2001040404-A1 COMPOSITION AND METHOD FOR INHIBITING POLYMERIZATION AND POLYMER GROWTH UNIROYAL CHEMICAL COMPANY, INC. (US) 2001-06-07 WO claimed
EP-1065197-A1 Process for preparing (meth)acrylic acid ROHM AND HAAS COMPANY (US) 2001-01-03 EP claimed
US-6048967-A Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute SYNZYME TECHNOLOGIES, INC. (US) 2000-04-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050049442-A1 Stabilized polychloroethylenes NFE2L2, GPX4, PCBP1 GAA 4296/4885L3MBTL1 724/4885
US-20020123658-A1 Recycle of nitroxyl-containing streams at low temperature NQO2, NOS2, NOS1 GAA 2720/4885L3MBTL1 3238/4885
US-20040010159-A1 Blends of quinone alkide and nitroxyl compounds and polymerization inhibitors SQOR, NQO1, NQO2 GAA 2247/4885L3MBTL1 2705/4885
US-20040039237-A1 Trichloroethane, is stabilized with a stabilizing amount of a stable free radical stabilizer, such as, 2,2,6,6,-tetra (lower alkyl)-1-piperidinyloxy-yl free radical group TTPA, TXN2, POT1 GAA 4120/4885L3MBTL1 735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.